OR52I1

Across TCGA pan-cancer cohorts, OR52I1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated OR52I1 data layer compared with 12 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher OR52I1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OR52I1 expression acts as an unfavorable survival marker.

BLCA, LUAD, and SKCM are the cancer types where OR52I1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.333	0.724	.001	30	view →
LUAD	OS	Median	All	0.223	0.788	.002	21	view →
SKCM	OS	Median	All	0.603	0.791	.014	13	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

OR52I1–BLCA (OS)

Open the BLCA breakdown →